Protective Roles for Caspase-8 and cFLIP in Adult Homeostasis

Cell Reports

Volumn 5, Issue 2, 2013, Pages 340-348

  Weinlich, Ricardo ^a   Oberst, Andrew ^b   Dillon, Christopher P ^a   Janke, Laura J ^a   Milasta, Sandra ^a   Lukens, John R ^a   Rodriguez, Diego A ^a   Gurung, Prajwal ^a   Savage, Chandra ^a   Kanneganti, Thirumala D ^a   Green, Douglas R ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; FLICE INHIBITORY PROTEIN; PROTEIN KINASE; RECEPTOR INTERACTING PROTEIN KINASE 3; TUMOR NECROSIS FACTOR ANTIBODY; UNCLASSIFIED DRUG; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; RIPK3 PROTEIN, MOUSE; TAMOXIFEN; TUMOR NECROSIS FACTOR;

ADULT ANIMAL; ADULTHOOD; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CONTROLLED STUDY; DEVELOPMENTAL BIOLOGY; DEVELOPMENTAL STAGE; DRUG MECHANISM; ENTERITIS; GENE DELETION; GENE DISRUPTION; GENE FUNCTION; GENE LOSS; GENE REPRESSION; HOMEOSTASIS; INTESTINE CELL; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPSIS; SKIN; TISSUE DISTRIBUTION; TISSUE METABOLISM; ANIMAL; APOPTOSIS; CYTOLOGY; DEFICIENCY; DRUG EFFECTS; GENETICS; KNOCKOUT MOUSE; METABOLISM; NEUTROPHIL; PATHOLOGY;

ANIMALIA; MUS;

ANIMALS; APOPTOSIS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASE 8; ENTEROCYTES; HOMEOSTASIS; MICE; MICE, KNOCKOUT; NEUTROPHILS; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; SKIN; TAMOXIFEN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84887016458     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2013.08.045     Document Type: Article

References (35)

1. Beisner D.R., Ch'en I.L., Kolla R.V., Hoffmann A., Hedrick S.M. Cutting edge: innate immunity conferred by B cells is regulated by caspase-8. J.Immunol. 2005, 175:3469-3473.
2. Bonnet M.C., Preukschat D., Welz P.S., van Loo G., Ermolaeva M.A., Bloch W., Haase I., Pasparakis M. The adaptor protein FADD protects epidermal keratinocytes from necroptosis invivo and prevents skin inflammation. Immunity 2011, 35:572-582.
3. Callus B.A., Vaux D.L. Caspase inhibitors: viral, cellular and chemical. Cell Death Differ. 2007, 14:73-78.
4. Chandler J.M., Cohen G.M., MacFarlane M. Different subcellular distribution of caspase-3 and caspase-7 following Fas-induced apoptosis in mouse liver. J.Biol. Chem. 1998, 273:10815-10818.
5. Dillon C.P., Oberst A., Weinlich R., Janke L.J., Kang T.B., Ben-Moshe T., Mak T.W., Wallach D., Green D.R. Survival function of the FADD-CASPASE-8-cFLIP(L) complex. Cell Rep. 2012, 1:401-407.
6. Duprez L., Takahashi N., Van Hauwermeiren F., Vandendriessche B., Goossens V., Vanden Berghe T., Declercq W., Libert C., Cauwels A., Vandenabeele P. RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome. Immunity 2011, 35:908-918.
7. Fuentes-Prior P., Salvesen G.S. The protein structures that shapecaspase activity, specificity, activation and inhibition. Biochem. J. 2004, 384:201-232.
8. Fulda S., Meyer E., Debatin K.M. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression. Cancer Res. 2000, 60:3947-3956.
9. Green D.R. Means to an End: Apoptosis and Other Cell Death Mechanisms 2010, Cold Spring Harbor Laboratory Press, New York. First Edition.
10. Günther C., Martini E., Wittkopf N., Amann K., Weigmann B., Neumann H., Waldner M.J., Hedrick S.M., Tenzer S., Neurath M.F., Becker C. Caspase-8 regulates TNF-α-induced epithelial necroptosis and terminal ileitis. Nature 2011, 477:335-339.
11. Irmler M., Thome M., Hahne M., Schneider P., Hofmann K., Steiner V., Bodmer J.L., Schröter M., Burns K., Mattmann C., et al. Inhibition of death receptor signals by cellular FLIP. Nature 1997, 388:190-195.
12. Jouan-Lanhouet S., Arshad M.I., Piquet-Pellorce C., Martin-Chouly C., Le Moigne-Muller G., Van Herreweghe F., Takahashi N., Sergent O., Lagadic-Gossmann D., Vandenabeele P., et al. TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation. Cell Death Differ. 2012, 19:2003-2014.
13. Kaiser W.J., Upton J.W., Long A.B., Livingston-Rosanoff D., Daley-Bauer L.P., Hakem R., Caspary T., Mocarski E.S. RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature 2011, 471:368-372.
14. Kang T.B., Ben-Moshe T., Varfolomeev E.E., Pewzner-Jung Y., Yogev N., Jurewicz A., Waisman A., Brenner O., Haffner R., Gustafsson E., et al. Caspase-8 serves both apoptotic and nonapoptotic roles. J.Immunol. 2004, 173:2976-2984.
15. Kang T.B., Yang S.H., Toth B., Kovalenko A., Wallach D. Caspase-8 blocks kinase RIPK3-mediated activation of the NLRP3 inflammasome. Immunity 2013, 38:27-40.
16. Kovalenko A., Kim J.C., Kang T.B., Rajput A., Bogdanov K., Dittrich-Breiholz O., Kracht M., Brenner O., Wallach D. Caspase-8 deficiency in epidermal keratinocytes triggers an inflammatory skin disease. J.Exp. Med. 2009, 206:2161-2177.
17. Krueger A., Schmitz I., Baumann S., Krammer P.H., Kirchhoff S. Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex. J.Biol. Chem. 2001, 276:20633-20640.
18. Künstle G., Leist M., Uhlig S., Revesz L., Feifel R., MacKenzie A., Wendel A. ICE-protease inhibitors block murine liver injury and apoptosis caused by CD95 or by TNF-alpha. Immunol. Lett. 1997, 55:5-10.
19. Lee P., Lee D.J., Chan C., Chen S.W., Ch'en I., Jamora C. Dynamic expression of epidermal caspase 8 simulates a wound healing response. Nature 2009, 458:519-523.
20. Linkermann A., Bräsen J.H., De Zen F., Weinlich R., Schwendener R.A., Green D.R., Kunzendorf U., Krautwald S. Dichotomy between RIP1- and RIP3-mediated necroptosis in tumor necrosis factor-α-induced shock. Mol. Med. 2012, 18:577-586.
21. McIlroy D., Tanaka M., Sakahira H., Fukuyama H., Suzuki M., Yamamura K., Ohsawa Y., Uchiyama Y., Nagata S. An auxiliary mode ofapoptotic DNA fragmentation provided by phagocytes. Genes Dev. 2000, 14:549-558.
22. Oberst A., Dillon C.P., Weinlich R., McCormick L.L., Fitzgerald P., Pop C., Hakem R., Salvesen G.S., Green D.R. Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature 2011, 471:363-367.
23. Piao X., Komazawa-Sakon S., Nishina T., Koike M., Piao J.H., Ehlken H., Kurihara H., Hara M., Van Rooijen N., Schütz G., et al. c-FLIP maintains tissue homeostasis by preventing apoptosis and programmed necrosis. Sci. Signal. 2012, 5:ra93.
24. Pockros P.J., Schiff E.R., Shiffman M.L., McHutchison J.G., Gish R.G., Afdhal N.H., Makhviladze M., Huyghe M., Hecht D., Oltersdorf T., Shapiro D.A. Oral IDN-6556, an antiapoptotic caspase inhibitor, may lower aminotransferase activity in patients with chronic hepatitis C. Hepatology 2007, 46:324-329.
25. Rajput A., Kovalenko A., Bogdanov K., Yang S.H., Kang T.B., Kim J.C., Du J., Wallach D. RIG-I RNA helicase activation of IRF3 transcription factor is negatively regulated by caspase-8-mediated cleavage of the RIP1 protein. Immunity 2011, 34:340-351.
26. Ratziu V., Sheikh M.Y., Sanyal A.J., Lim J.K., Conjeevaram H., Chalasani N., Abdelmalek M., Bakken A., Renou C., Palmer M., et al. A phase 2, randomized, double-blind, placebo-controlled study of GS-9450 in subjects with nonalcoholic steatohepatitis. Hepatology 2012, 55:419-428.
27. Salmena L., Lemmers B., Hakem A., Matysiak-Zablocki E., Murakami K., Au P.Y., Berry D.M., Tamblyn L., Shehabeldin A., Migon E., et al. Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity. Genes Dev. 2003, 17:883-895.
28. Varfolomeev E.E., Schuchmann M., Luria V., Chiannilkulchai N., Beckmann J.S., Mett I.L., Rebrikov D., Brodianski V.M., Kemper O.C., Kollet O., et al. Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity 1998, 9:267-276.
29. Vince J.E., Wong W.W., Gentle I., Lawlor K.E., Allam R., O'Reilly L., Mason K., Gross O., Ma S., Guarda G., et al. Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin-1 activation. Immunity 2012, 36:215-227.
30. Wallach D., Kang T.B., Rajput A., Kim J.C., Bogdanov K., Yang S.H., Kovalenko A. Anti-inflammatory functions of the "apoptotic" caspases. Ann. N Y Acad. Sci. 2010, 1209:17-22.
31. Weinlich R., Dillon C.P., Green D.R. Ripped to death. Trends Cell Biol. 2011, 21:630-637.
32. Welz P.S., Wullaert A., Vlantis K., Kondylis V., Fernández-Majada V., Ermolaeva M., Kirsch P., Sterner-Kock A., van Loo G., Pasparakis M. FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation. Nature 2011, 477:330-334.
33. Yeh W.C., de la Pompa J.L., McCurrach M.E., Shu H.B., Elia A.J., Shahinian A., Ng M., Wakeham A., Khoo W., Mitchell K., et al. FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science 1998, 279:1954-1958.
34. Yeh W.C., Itie A., Elia A.J., Ng M., Shu H.B., Wakeham A., Mirtsos C., Suzuki N., Bonnard M., Goeddel D.V., Mak T.W. Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development. Immunity 2000, 12:633-642.
35. Zhang D.W., Shao J., Lin J., Zhang N., Lu B.J., Lin S.C., Dong M.Q., Han J. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 2009, 325:332-336.